|
Mapping
emerging markets
Making a mark in the MENA markets has been an uphill task
for Indian pharmaceutical companies. Usha Sharma analyses
Pfizer
to acquire Wyeth
Pfizer and Wyeth recently entered into a definitive merger
agreement. Pfizer will acquire Wyeth in a cash-and-stock transaction
currently valued at $50.19 per share, or a total of approximately
$68 billion
Ranbaxy-GSK
lead compound enters phase I
Ranbaxy Laboratories' New Drug Discovery Development Research
(NDDR) team has achieved a significant landmark in its collaborative
research programme with GlaxoSmithKline (GSK)
Elder
Pharma ties up with Australian firm
Elder Pharmaceuticals has tied-up with Australia's Global
Energy Medicines (GEM) for introducing into India non-invasive,
electro-therapy based energy medicines for pain management
through the use of personal microelectronic devices which
stimulate the body's own natural recovery and repair processes
Lupin
settles litigation with Schering-Plough
Lupin has settled all ongoing Hatch-Waxman litigation relating
to Desloratadine tablets, which is the generic version of
Schering-Plough's 'Clarinex' tablets
Troikaa
on expansion spree
Troikaa Pharmaceuticals is setting up greenfield manufacturing
facilities for pharma as well as biotech products at Sanand
in Ahmedabad
Event
Brief
USP-IPC
scheduling 8th 'Annual Scientific Meet' in Hyderabad
Following the success of its seventh Annual Scientific Meeting
(ASM), the United States Pharmacopeial (USP) Convention in
association with Indian Pharmacopoeia Commission (IPC) is
organising its eighth ASM on February 11-12, 2009 in Hyderabad
ISCR
holds 2nd annual conference
The second annual conference of the Indian Society for Clinical
Research (ISCR) was held on January 11-12, 2009 in Mumbai
60th
IPC sets high standards
The 60th IPC went on to become a grand success as it became
a catalyst in initiating landmark resolutions. An Express
Pharma report
ORG
IMS - IDMA SME Forum woos Gujarat SMEs
Tailored to address the concerns of SME players in the pharmaceutical
industry, the Forum gave crucial insights into what out-performing
companies are doing to prepare for the challenging days ahead.
An exclusive Express Pharma report
|
